Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Sees Significant Growth in Short Interest

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 31st, there was short interest totalling 212,500 shares, an increase of 1,560.2% from the August 15th total of 12,800 shares. Based on an average daily volume of 735,300 shares, the days-to-cover ratio is currently 0.3 days.

Reckitt Benckiser Group Price Performance

RBGLY stock traded up $0.07 during midday trading on Friday, hitting $12.15. 180,762 shares of the company’s stock were exchanged, compared to its average volume of 893,771. The business has a 50-day simple moving average of $11.27 and a two-hundred day simple moving average of $11.38. Reckitt Benckiser Group has a 1-year low of $10.24 and a 1-year high of $15.03.

Reckitt Benckiser Group Cuts Dividend

The firm also recently announced a dividend, which will be paid on Monday, September 23rd. Shareholders of record on Monday, August 5th will be paid a dividend of $0.1915 per share. The ex-dividend date is Monday, August 5th.

Analyst Ratings Changes

Separately, JPMorgan Chase & Co. cut Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a report on Thursday, August 29th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, Reckitt Benckiser Group presently has a consensus rating of “Hold” and a consensus price target of $7,400.00.

View Our Latest Research Report on Reckitt Benckiser Group

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

See Also

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.